首页
产品目录
分子砌块
按官能团
试剂
(R)-1-(3-(氨基甲基)苯基)-N-(5-((3-氰基苯基)((环丙基甲基)氨基)甲基)-2-氟苯基)-3-(三氟甲基)-1H-吡唑-5-甲酰胺二盐酸盐
(R)-1-(3-(氨基甲基)苯基)-N-(5-((3-氰基苯基)((环丙基甲基)氨基)甲基)-2-氟苯基)-3-(三氟甲基)-1H-吡唑-5-甲酰胺二盐酸盐
(R)-1-(3-(Aminomethyl)phenyl)-N-(5-((3-cyanophenyl)((cyclopropylmethyl)amino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride
产品编号 :
ACMFFN207
Cas No. :
1809010-52-3
包装规格
纯度
目录价
会员专享价
库存
数量
1mg
98%
¥5332
询价
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。
基础信息
CAS No.
1809010-52-3
中文名称
(R)-1-(3-(氨基甲基)苯基)-N-(5-((3-氰基苯基)((环丙基甲基)氨基)甲基)-2-氟苯基)-3-(三氟甲基)-1H-吡唑-5-甲酰胺二盐酸盐
英文名称
(R)-1-(3-(Aminomethyl)phenyl)-N-(5-((3-cyanophenyl)((cyclopropylmethyl)amino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride
别名
Berotralstat hydrochloride;Berotralstat dihydrochloride;Berotralstat HCl
标准英文名
(R)-1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)((cyclopropylmethyl)amino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide dihydrochloride
分子式
C3 0 H2 8 Cl2 F4 N6 O
分子量
635.49
精确分子量
634.16
SMILES
O=C(C1=CC(C(F)(F)F)=NN1C2=CC=CC(CN)=C2)NC3=CC([C@@H](C4=CC=CC(C#N)=C4)NCC5CC5)=CC=C3F.[H]Cl.[H]Cl
标准SMILES
Cl.Cl.NCC1C=CC=C(C=1)N1N=C(C=C1C(=O)NC1=CC(=CC=C1F)[C@H](NCC1CC1)C1C=C(C=CC=1)C#N)C(F)(F)F
用途
Berotralstat hydrochloride is used for the prevention of hereditary angioedema (HAE) attacks in adult and pediatric patients; it is an oral plasma kallikrein inhibitor that reduces bradykinin production by inhibiting plasma kallikrein, thereby alleviating symptoms of HAE; it was approved by the US FDA in December 2020 as the first oral, non-steroidal medication for the prophylaxis of HAE attacks.
InChIKey
XFZLBLTUANGZBD-QDSLRZTOSA-N